Medtronic said Friday it has received CE Mark for a suite of quadripolar cardiac resynchronization therapy pacemakers (CRT-Ps) which allow patients to receive MRI scans in either 1.5 or 3 Tesla machines.
The complete line of CRT-Ps available in Europe in March includes the Percepta Quad, Serena Quad and Solara Quad CRT-P MRI SureScan. These devices are not yet approved for sale in the U.S
“With the addition of quadripolar CRT-P devices to our heart failure portfolio, we now offer a comprehensive line of CRT devices to further meet the needs of patients throughout Europe,” said David Steinhaus, M.D., VP and general manager of the Heart Failure business, and medical director for the Cardiac Rhythm and Heart Failure division of Medtronic.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.